Fonterelli SPAC 2 Aktie
WKN DE: A3MQR6 / ISIN: DE000A3MQR65
|
26.11.2025 17:02:53
|
EQS-Adhoc: Viromed confirms talks with an international MedTech company regarding a cooperation in the field of wound care
|
EQS-Ad-hoc: Viromed Medical AG / Key word(s): Alliance/Miscellaneous AD HOC ANNOUNCEMENT Pinneberg, November 26, 2025 – Viromed Medical AG ("Viromed"; ISIN: DE000A3MQR65), confirms market rumors that the company is in advanced talks with a global MedTech company in the field of wound treatment about signing a cooperation agreement. This mainly involves the use of the cold plasma medical device ViroCAP®/OEM to support wound healing. Viromed will inform shareholders of further developments in an appropriate manner and in accordance with the legal obligations.
End of Inside Information
26-Nov-2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
| Language: | English |
| Company: | Viromed Medical AG |
| Hauptstraße 105 | |
| 25462 Rellingen | |
| Germany | |
| E-mail: | kontakt@viromed-medical.de |
| Internet: | https://www.viromed-medical-ag.de/ |
| ISIN: | DE000A3MQR65 |
| WKN: | A3MQR6 |
| Listed: | Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt, Hamburg, Tradegate Exchange |
| EQS News ID: | 2236382 |
| End of Announcement | EQS News Service |
|
|
2236382 26-Nov-2025 CET/CEST
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Fonterelli SPAC 2 AG Inhaber-Aktmehr Nachrichten
|
26.11.25 |
EQS-Adhoc: Viromed bestätigt Gespräche mit internationalem MedTech-Konzern hinsichtlich Kooperation im Bereich der Wundbehandlung (EQS Group) | |
|
26.11.25 |
EQS-Adhoc: Viromed confirms talks with an international MedTech company regarding a cooperation in the field of wound care (EQS Group) | |
|
27.10.25 |
EQS-DD: Viromed Medical AG: Uwe Perbandt, sell (EQS Group) | |
|
27.10.25 |
EQS-DD: Viromed Medical AG: Uwe Perbandt, Verkauf (EQS Group) | |
|
24.10.25 |
EQS-DD: Viromed Medical AG: Uwe Perbandt, sell (EQS Group) | |
|
24.10.25 |
EQS-DD: Viromed Medical AG: Uwe Perbandt, Verkauf (EQS Group) | |
|
21.10.25 |
EQS-News: Viromed Medical AG: Umplatzierungen von Viromed-Aktien erweitern Investorenbasis (EQS Group) | |
|
21.10.25 |
EQS-News: Viromed Medical AG: Reallocation of Viromed shares broadens investor base (EQS Group) |
Analysen zu Fonterelli SPAC 2 AG Inhaber-Aktmehr Analysen
Aktien in diesem Artikel
| Fonterelli SPAC 2 AG Inhaber-Akt | 3,56 | -1,11% |
|